Hard to Treat Diseases Inc. (HTDS)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Aug 15, 2025
Hard to Treat Diseases Market Cap
Hard to Treat Diseases has a market cap or net worth of $5.82 thousand as of August 22, 2025.
Market Cap
5.82K
Enterprise Value
n/a
Revenue
6.16M
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since February 20, 2009, Hard to Treat Diseases's market cap has decreased from 56.96K to 5.82K, a decrease of -89.78%. That is a compound annual growth rate of -12.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 5.82K | - |
| Dec 31, 2024 | 5.82K | - |
| Dec 29, 2023 | 5.82K | - |
| Dec 30, 2022 | 5.82K | - |
| Dec 31, 2021 | 5.82K | -99.00% |
| Dec 31, 2020 | 581.93K | - |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |